Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
274 hedge funds and large institutions have $3.94B invested in Abiomed Inc in 2016 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 109 increasing their positions, 83 reducing their positions, and 33 closing their positions.
423% more call options, than puts
Call options by funds: $51.4M | Put options by funds: $9.84M
85% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 33
31% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 83
10% more funds holding
Funds holding: 249 → 274 (+25)
10% more capital invested
Capital invested by funds: $3.58B → $3.94B (+$358M)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$67.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$40M |
| 3 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$38.7M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$33.8M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$28.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$59.1M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$47.6M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$44.3M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$22.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACS
301
Archford Capital Strategies
Swansea,
Illinois
| – | -$37K | -400 | Closed |
|
|
DSC
302
Duncker Streett & Co
St. Louis,
Missouri
| – | -$27K | -300 | Closed |
|
|
TDC
303
Thompson Davis & Co
Richmond,
Virginia
| – | -$23K | -250 | Closed |
|
304
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$10K | -109 | Closed |
|
|
CG
305
Colony Group
Boston,
Massachusetts
| – | -$5K | -50 | Closed |
|
|
VCM
306
Versant Capital Management
Phoenix,
Arizona
| – | -$169 | -2 | -18% |
|
ABMD Hedge Fund Activity: Q1 2016 in Review
274 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2016, worth a combined $3.94B — up 10% from $3.58B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new ABMD positions and 33 closed out — a net gain of 28 holders — while 109 added to existing stakes and 83 trimmed.
The largest buyer was 1832 Asset Management, opening a new position worth an estimated $67.6M. The largest seller was Essex Woodlands Management, cutting an estimated $59.1M.
- 274 institutional investors held Abiomed Inc (ABMD) as of Q1 2016, up from 249 in Q4 2015.
- Funds reported $3.94B of Abiomed Inc stock for Q1 2016, up 10% quarter-over-quarter.
- 61 funds opened new Abiomed Inc positions in Q1 2016 and 33 closed out, a net change of +28 holders.
- The largest Abiomed Inc buyer in Q1 2016 was 1832 Asset Management, an estimated $67.6M added.
- The largest Abiomed Inc seller in Q1 2016 was Essex Woodlands Management, an estimated $59.1M sold.
Based on aggregated 13F filings for Q1 2016.